OHE Publications

OHE releases a number of publications throughout the year, authored by OHE team members and/or outside experts. All are free for download as pdf files; hard copies of some publications are available upon request.

A description of the OHE publications categories.


Dolan, P.

November 2011

In this new report, Prof Paul Dolan provides an accessible guide into the latest developments in happiness research as they apply to the valuation of health.  This report considers the degree to which happiness data can overcome some of the well-known problems with existing preference-based ways of valuing health.  It presents new valuation data that show how the dimensions of health that matter most in happiness regressions are not the same as those that matter most when people are asked about their preferences.  In particular, mental health matters more in happiness reports

Devlin, N., Buckingham, K., Shah, K., Tsuchiya, A., Tilling, C., Wilkinson, G. and van Hout, B.

Research Paper
December 2010

OHE was awarded a UK Department of Health grant to further develop three aspects of health status indexes.  Results of the second of these, advances in Time Trade Off (TTO) methodology, are reported in this OHE Research Paper.

Culyer, A.

June 2009

In the UK and elsewhere, choices about how to allocate health care resources are guided not only by economic calculations, but also by social value judgments such as those relating to equity and fairness. Factors such as uncertainty around key values, operational feasibility and stakeholder interests also need to be considered. The question of how to combine these inputs is central to the field of health care decision making.

Kahneman, D.

August 2008

OHE’s 14th Annual Lecture was delivered by Professor Daniel Kahneman, winner of the 2002 Nobel Prize in Economic Sciences for his pioneering work integrating insights from psychological research into economic science, especially concerning human judgment and decision-making under uncertainty.  His focus in the lecture was on whether and how the utility of health states can be measured and whether QALYs are adequate.  He suggests that there are reasonable grounds for measuring both decision utility and experience utility, using measures that are duration-weighted and others that ar

Cross, J.T. and Garrison, L.

August 2008

This Briefing reports the discussions of a group of experts at an OHE workshop on the benefit-risk assessments of drugs. The objective was to identify how particular tools and methods used in economic analysis and the decision sciences might improve the methodologies that regulatory authorities apply to evaluate drug benefit and risk.

Chauhan, D. and Sussex, J.

March 2008

About one pound of every eleven spent in the UK goes to health care, most to NHS care. A large body of data is available on health care inputs and expenditures; far less is known about the outcomes that the resources and activities produce. Yet, knowing the outcomes achieved by health services is essential to being able to achieve the greatest benefit, the best patient care, from the resources used. The effectiveness, efficiency and accountability of the NHS all depend on knowing the outcomes it is achieving.